id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OAR-2006-0159-0033,EPA,EPA-HQ-OAR-2006-0159,"Notes from meeting between representatives from Amphastar Pharmaceuticals, Inc./Armstrong Pharmaceuticals Inc. and USEPA on November 30, 2006",Supporting & Related Material,Meeting/Teleconference Materials,2006-12-06T05:00:00Z,2006,12,,,2012-03-24T19:34:44Z,,0,0,09000064801e76bb
EPA-HQ-OAR-2006-0159-0001,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2007,Proposed Rule,Federal Register Document,2006-11-03T12:49:10Z,2006,11,2006-11-03T12:49:10Z,2006-12-05T04:59:59Z,2011-06-11T16:02:04Z,E6-18581,0,0,09000064801dd141
EPA-HQ-OAR-2006-0159-0021,EPA,EPA-HQ-OAR-2006-0159,Placeholder for the Regulatory Impact Analysis RIA,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:45Z,,0,0,09000064801dbe94
EPA-HQ-OAR-2006-0159-0008,EPA,EPA-HQ-OAR-2006-0159,Placeholder for Schering Plough's response to Section 114 letter,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:37Z,,0,0,09000064801db554
EPA-HQ-OAR-2006-0159-0018,EPA,EPA-HQ-OAR-2006-0159,SAMPLE 114 Letter for Allocation of Essential Use Allowances for Calendar Year 2007,Supporting & Related Material,"Letter, Memorandum, Email",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:43Z,,0,0,09000064801dbe5e
EPA-HQ-OAR-2006-0159-0017,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for Armstrong Pharmaceuticals, Inc.’s response to 114 letter regarding CFC stocks owned",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:42Z,,0,0,09000064801dbe40
EPA-HQ-OAR-2006-0159-0007,EPA,EPA-HQ-OAR-2006-0159,Placeholder for Wyeth's response to Section 114 letter,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:37Z,,0,0,09000064801db534
EPA-HQ-OAR-2006-0159-0016,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for Boehringer Ingelheim Pharmaceuticals, Inc.’s response to 114 letter regarding CFC stocks owned",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:42Z,,0,0,09000064801dbe3a
EPA-HQ-OAR-2006-0159-0013,EPA,EPA-HQ-OAR-2006-0159,Schering-Plough's response to 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:40Z,,0,0,09000064801dbd2b
EPA-HQ-OAR-2006-0159-0015,EPA,EPA-HQ-OAR-2006-0159,Placeholder for Wyeth's response to section 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:41Z,,0,0,09000064801dbe1d
EPA-HQ-OAR-2006-0159-0023,EPA,EPA-HQ-OAR-2006-0159,Decision IV/25- Essential uses,Supporting & Related Material,"Guidance, Interpretation, Policy, Procedure",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:46Z,,0,0,09000064801dbef4
EPA-HQ-OAR-2006-0159-0004,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for Boehringer Ingelheim Pharmaceuticals, Inc’s response to Section 114 letter",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:35Z,,0,0,09000064801d7f4b
EPA-HQ-OAR-2006-0159-0006,EPA,EPA-HQ-OAR-2006-0159,Placeholder for 3M’s response to Section 114 letter,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:36Z,,0,0,09000064801d7fbd
EPA-HQ-OAR-2006-0159-0022,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2006,Supporting & Related Material,Federal Register Document,2006-11-03T05:00:00Z,2006,11,,,2011-06-11T16:02:04Z,,0,0,09000064801dbedc
EPA-HQ-OAR-2006-0159-0024,EPA,EPA-HQ-OAR-2006-0159,Decision XVI/12-Essential-use nominations for Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol for controlled substances for 2005 and 2006,Supporting & Related Material,,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:47Z,,0,0,09000064801dbf01
EPA-HQ-OAR-2006-0159-0020,EPA,EPA-HQ-OAR-2006-0159,Decision XVII/5: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2006 and 2007,Supporting & Related Material,"Guidance, Interpretation, Policy, Procedure",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:44Z,,0,0,09000064801dbe7e
EPA-HQ-OAR-2006-0159-0010,EPA,EPA-HQ-OAR-2006-0159,SAMPLE 114 LETTER for CFC Stocks Owned,Supporting & Related Material,"Letter, Memorandum, Email",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:38Z,,0,0,09000064801dbcf0
EPA-HQ-OAR-2006-0159-0019,EPA,EPA-HQ-OAR-2006-0159,"Letter to Brian McLean, Director, Office of Atmospheric Programs, USEPA re: responding to the March 23 letter requesting the Food and Drug Administration's (FDA) re: 2007 Essential Use Allowances",Supporting & Related Material,"Letter, Memorandum, Email",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:44Z,,0,0,09000064801dbe6a
EPA-HQ-OAR-2006-0159-0003,EPA,EPA-HQ-OAR-2006-0159,"Letter to Mr. Andrew C. von Eschenbach, M.D., Acting Commissioner of Food and Drugs, Food and Drug Administration",Supporting & Related Material,"Letter, Memorandum, Email",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:34Z,,0,0,09000064801d7e7f
EPA-HQ-OAR-2006-0159-0005,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for Inyx USA, Ltd.’s response to Section 114 letter",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:36Z,,0,0,09000064801d7f7a
EPA-HQ-OAR-2006-0159-0011,EPA,EPA-HQ-OAR-2006-0159,Placeholder for Inyx USA Ltd.'s response to 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:39Z,,0,0,09000064801dbd07
EPA-HQ-OAR-2006-0159-0002,EPA,EPA-HQ-OAR-2006-0159,"CBI Placeholder for Armstrong Pharmaceuticals, Inc.’s response to Section 114 letter",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:34Z,,0,0,09000064801d76c1
EPA-HQ-OAR-2006-0159-0014,EPA,EPA-HQ-OAR-2006-0159,Honeywell's response to 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:41Z,,0,0,09000064801dbd47
EPA-HQ-OAR-2006-0159-0012,EPA,EPA-HQ-OAR-2006-0159,3M's response to 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:40Z,,0,0,09000064801dbd1e
EPA-HQ-OAR-2006-0159-0009,EPA,EPA-HQ-OAR-2006-0159,United States' Nomination of The Aerosol Metered Dose Inhaler (MDI) As An Essential Use,Supporting & Related Material,,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:38Z,,0,0,09000064801dbc8d